PMC:7212965 / 65604-66248 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T152","span":{"begin":319,"end":324},"obj":"Body_part"},{"id":"T153","span":{"begin":350,"end":355},"obj":"Body_part"}],"attributes":[{"id":"A152","pred":"fma_id","subj":"T152","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A153","pred":"fma_id","subj":"T153","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T120","span":{"begin":319,"end":324},"obj":"Body_part"},{"id":"T121","span":{"begin":350,"end":355},"obj":"Body_part"}],"attributes":[{"id":"A120","pred":"uberon_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A121","pred":"uberon_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T329","span":{"begin":190,"end":198},"obj":"Disease"},{"id":"T330","span":{"begin":429,"end":437},"obj":"Disease"}],"attributes":[{"id":"A329","pred":"mondo_id","subj":"T329","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A330","pred":"mondo_id","subj":"T330","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T469","span":{"begin":319,"end":324},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T470","span":{"begin":319,"end":324},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T471","span":{"begin":350,"end":355},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T472","span":{"begin":350,"end":355},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T473","span":{"begin":520,"end":522},"obj":"http://purl.obolibrary.org/obo/CLO_0053799"},{"id":"T474","span":{"begin":530,"end":532},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T475","span":{"begin":571,"end":573},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T77744","span":{"begin":93,"end":95},"obj":"Chemical"},{"id":"T2261","span":{"begin":515,"end":518},"obj":"Chemical"},{"id":"T13797","span":{"begin":597,"end":606},"obj":"Chemical"}],"attributes":[{"id":"A63480","pred":"chebi_id","subj":"T77744","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A19680","pred":"chebi_id","subj":"T2261","obj":"http://purl.obolibrary.org/obo/CHEBI_76649"},{"id":"A81558","pred":"chebi_id","subj":"T13797","obj":"http://purl.obolibrary.org/obo/CHEBI_16990"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T297","span":{"begin":429,"end":437},"obj":"Phenotype"},{"id":"T298","span":{"begin":478,"end":486},"obj":"Phenotype"}],"attributes":[{"id":"A297","pred":"hp_id","subj":"T297","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A298","pred":"hp_id","subj":"T298","obj":"http://purl.obolibrary.org/obo/HP_0002013"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T515","span":{"begin":0,"end":57},"obj":"Sentence"},{"id":"T516","span":{"begin":58,"end":112},"obj":"Sentence"},{"id":"T517","span":{"begin":113,"end":174},"obj":"Sentence"},{"id":"T518","span":{"begin":175,"end":225},"obj":"Sentence"},{"id":"T519","span":{"begin":226,"end":276},"obj":"Sentence"},{"id":"T520","span":{"begin":277,"end":302},"obj":"Sentence"},{"id":"T521","span":{"begin":303,"end":339},"obj":"Sentence"},{"id":"T522","span":{"begin":340,"end":380},"obj":"Sentence"},{"id":"T523","span":{"begin":381,"end":428},"obj":"Sentence"},{"id":"T524","span":{"begin":429,"end":438},"obj":"Sentence"},{"id":"T525","span":{"begin":439,"end":487},"obj":"Sentence"},{"id":"T526","span":{"begin":488,"end":523},"obj":"Sentence"},{"id":"T527","span":{"begin":524,"end":564},"obj":"Sentence"},{"id":"T528","span":{"begin":565,"end":612},"obj":"Sentence"},{"id":"T529","span":{"begin":613,"end":644},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2394","span":{"begin":190,"end":198},"obj":"Disease"},{"id":"2395","span":{"begin":350,"end":370},"obj":"Disease"},{"id":"2396","span":{"begin":429,"end":437},"obj":"Disease"},{"id":"2397","span":{"begin":478,"end":486},"obj":"Disease"}],"attributes":[{"id":"A2394","pred":"tao:has_database_id","subj":"2394","obj":"MESH:C000657245"},{"id":"A2395","pred":"tao:has_database_id","subj":"2395","obj":"MESH:D017093"},{"id":"A2396","pred":"tao:has_database_id","subj":"2396","obj":"MESH:D003967"},{"id":"A2397","pred":"tao:has_database_id","subj":"2397","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" Shu, 202041Cabin Hospital of Wuhan Stadium (Wuhan)Dates: 2/13/2020-2/29/2020Last follow-up: NR n = 545Survival: 85.9% discharged, 14.1% still hospitalized, 0% diedInclusion: Inpatient with COVID-19 confirmed based on RT-PCR. Severe cases requiring transfer were excluded.Age: M 50 y (IQR, 38–58 y)Sex: 51.2% femalesGI/liver comorbidities: 0 chronic liver diseaseDisease severity: 2.9% mild, 97.1% moderate, 0 severe (excluded). Diarrhea: 8.9% (49)Present on admissionNausea or vomiting: 0% (0)Present on admission AST \u003e45: 6.4% (35)M 32.1 (IQR, 24.5–36.4)ALT \u003e50: 7.5% (41)M 34.6 (IQR, 26.2–42.3)Bilirubin \u003e1.2: 34.7% (189)M 1.1 (IQR, 0.8–1.3)"}